![Plasmatic and phenotypic effects with alirocumab, a PCSK9 inhibitor, in familial hypercholesterolemia treatment (FH)]()
Plasmatic and phenotypic effects with alirocumab, a PCSK9 inhibitor, in familial hypercholesterolemia treatment (FH)Simonelli, Francesca; Miotti, Cristiano; Filice, Barbara Fausta; Gallo, Giovanna; Burocchi, Simone; Presta, Vivanne; Salerno, Gerardo; Abbolito, Sofia; Volpe, Massimo; De Biase, Luciano · Atherosclerosis · 2017